The gingipains: Scissors and glue of the periodontal pathogen, Porphyromonas gingivalis

Future Microbiology

Volumn 4, Issue 4, 2009, Pages 471-487

  Fitzpatrick, Rebecca Elsie ^a   Wijeyewickrema, Lakshmi C ^a   Pike, Robert N ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Adhesin domains; Cysteine proteases; Gingipains; Periodontal disease; Porphyromonas gingivalis

Indexed keywords

ADHESIN; ARGININE GINGIPAIN A; ARGININE GINGIPAIN B; BACTERIAL ENZYME; GINGIPAIN; HEMAGGLUTININ; LYSINE GINGIPAIN; MATRIX METALLOPROTEINASE; PROTEINASE; TRYPTASE; UNCLASSIFIED DRUG; VIRULENCE FACTOR; ARGINGIPAIN, PORPHYROMONAS GINGIVALIS; CYSTEINE PROTEINASE;

BACTERIAL VIRULENCE; CARBOXY TERMINAL SEQUENCE; CRYSTAL STRUCTURE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME STRUCTURE; HUMAN; NONHUMAN; PERIODONTAL DISEASE; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN MOTIF; REVIEW; CHEMISTRY; GENETICS; PATHOGENICITY; PHYSIOLOGY;

BACTERIA (MICROORGANISMS); PORPHYROMONAS GINGIVALIS;

ADHESINS, BACTERIAL; CYSTEINE ENDOPEPTIDASES; PORPHYROMONAS GINGIVALIS; VIRULENCE FACTORS;

EID: 66949139751     PISSN: 17460913     EISSN: None     Source Type: Journal    
DOI: 10.2217/fmb.09.18     Document Type: Review

References (176)

1. Brown LJ, Johns BA, Wall TP: The economics of periodontal diseases. Periodontol. 200029(1), 223-234 (2002).
2. Armitage GC: Classifying periodontal diseases - a long-standing dilemma. Periodontol. 2000 30, 9-23 (2002).
3. Lamont RJ, Jenkinson HF: Life below the gum line: pathogenic mechanisms of Porphyromonas gingivalis. Microbiol. Mol. Biol. Rev. 62(4), 1244-1263 (1998).
4. Armitage GC: Periodontal diagnoses and classification of periodontal diseases. Periodontol. 2000 34, 9-21 (2004).
5. Kinane DF: Causation and pathogenesis of periodontal disease. Periodontol. 2000 25, 8-20 (2001).
6. Williams RC, Barnett AH, Claffey N et al.: The potential impact of periodontal disease on general health: a consensus view. Curr. Med. Res. Opin 24, 1635-1643 (2008).
7. Bahekar AA, Singh S, Saha S et al.: The prevalence and incidence of coronary heart disease is significantly increased in periodontitis: a meta-analysis. Am. Heart J. 154(5), 830-837 (2007).
8. Saremi A, Neison RG, Tulloch-Reid M et al.: Periodontal disease and mortality in Type 2 diabetes. Diabetes Care 28(1), 27-32 (2005).
9. Khader YS, Dauod AS, El-Qaderi SS et al.: Periodontal status of diabetics compared with nondiabetics: a meta-analysis. J. Diabetes Complicat. 20, 59-68 (2006).
10. Offenbacher S, Katz V, Fertik G et al.: Periodontal infection as a possible risk factor for preterm low birth weight. J. Periodontol. 67, 1103-1113 (1996).
11. Dasanayake AP: Poor periodontal health of the pregnant woman as a risk factor for low birth weight. Ann. Periodontol. 3, 206-212 (1998).
12. Jeffcoat MK, Geurs NC, Reddy MS et al.: Periodontal infection and preterm birth: results of a prospective study. J. Am. Dent. Assoc. 132(7), 875-880 (2001).
13. Mercado FB, Marshall RI, Bartold PM: Inter-relationships between rheumatoid arthritis and periodontal disease. A review. J. Clin. Periodontol. 30, 761-772 (2003).
14. Shultis WA, Weil EJ, Looker HC et al.: Effect of periodontitis on overt nephropathy and end-stage renal disease in Type 2 diabetes. Diabetes Care 30(2), 306-311 (2007).
15. Garcia RI, Nunn ME, Vokonas PS: Epidemiologic associations between periodontal disease and chronic obstructive pulmonary disease. Ann. Periodontol. 6(1), 71-77 (2001).
16. Meyer MS, Joshipura K, Giovannucci E et al.: A review of the relationship between tooth loss, periodontal disease, and cancer. Cancer Causes Control 19, 895-907 (2008).
17. Slots J: Subgingival microflora and periodontal disease. J. Clin. Periodontol. 6, 351-382 (1979).
18. Listgarten MA: The role of dental plaque in gingivitis and periodontitis. J. Clin. Periodontol. 15, 485-487 (1988).
19. Holt SC, Ebersole JL: Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia: the 'red complex', a prototype polybacterial pathogenic consortium in periodontitis. Periodontol. 2000 38, 72-122 (2005).
20. Pihlstrom BL, Michalowicz BS, Johnson NW: Periodontal diseases. Lancet 366(9499), 1809-1820 (2005).
21. Socransky SS, Haffajee AD, Cugini MA et al.: Microbial complexes in subgingival plaque. J. Clin. Periodontol. 25, 134-144 (1998).
22. Socransky SS, Haffajee AD: Periodontal microbial ecology. Periodontol. 2000 38, 135-187 (2005).
23. Ximenez-Fyvie LA, Almaguer-Flores A, Jacobo-Soto V et al.: Description of the subgingival microbiota of periodontally untreated Mexican subjects: chronic periodontitis and periodontal health. J. Periodontol. 77(3), 460-471 (2006).
24. Lopez NJ, Socransky SS, Da Silva I et al.: Subgingival microbiota of Chilean patients with chronic periodontitis. J. Periodontol. 75(5), 717-725 (2004).
25. Haffajee AD, Socransky SS: Microbial etiological agents of destructive periodontal diseases. Periodontol. 2000 5(1), 78-111 (1994).
26. Slots J: Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in periodontal disease: introduction. Periodontol. 2000 20, 7-13 (1999).
27. Gibson FC, Genco CA: The genus Porphyromonas. In: The Prokaryotes. Dworkin M, Falkow S, Rosenberg E, Schleifer KH, Stackebrandt E (Eds). Springer, New York, USA (2006).
28. Gibbons RJ, Macdonald JB: Hemin and vitamin K compounds as required factors for the cultivation of certain strains of Bacteroides melaninogenicus. J. Bacteriol. 80, 164-170 (1960).
29. Shah HN, Bonnett R, Mateen B et al.: The porphyrin pigmentation of subspecies of Bacteroides melaninogenicus. Biochem. J. 180(1), 45-50 (1979).
30. Genco CA: Regulation of hemin and iron transport in Porphyromonas gingivalis. Adv. Dent. Res. 9, 41-47 (1995).
31. McKee AS, McDermid AS, Baskerville A et al.: Effect of hemin on the physiology and virulence of Bacteroides gingivalis W50. Infect. Immun. 52(2), 349-355 (1986).
32. Naito M, Hirakawa H, Yamashita A et al.: Determination of the genome sequence of Porphyromonas gingivalis strain ATCC 33277 and genomic comparison with strain W83 revealed extensive genome rearrangements in P. gingivalis. DNA Res. 15(4), 215-225 (2008).
33. Nelson KE, Fleischmann RD, DeBoy RT et al.: Complete genome sequence of the oral pathogenic Bacterium Porphyromonas gingivalis strain W83. J. Bacteriol. 185(18), 5591-5601 (2003).
34. Lamont RJ, Jenkinson HF: Subgingival colonization by Porphyromonas gingivalis. Oral Microbiol. Immunol. 15(6), 341-349 (2000).
35. Lamont RJ, Yilmaz O: In or out: the invasiveness of oral bacteria. Periodontol. 2000 30, 61-69 (2002).
36. Amano A: Molecular interaction of Porphyromonas gingivalis with host cells: implication for the microbial pathogenesis of periodontal disease. J. Periodontol. 74(1), 90-96 (2003).
37. Holt SC, Kesavalu L, Walker S et al.: Virulence factors of Porphyromonas gingivalis. Periodontol. 2000 20, 168-238 (1999).
38. O'Brien-Simpson NM, Veith PD, Dashper SG et al.: Antigens of bacteria associated with periodontitis. Periodontol. 2000 35, 101-134 (2004).
39. O'Brien-Simpson NM, Veith PD, Dashper SG et al.: Porphyromonas gingivalis gingipains: the molecular teeth of a microbial vampire. Curr. Protein Pept. Sci. 4, 409-426 (2003).
40. Potempa J, Banbula A, Travis J: Role of bacterial proteinases in matrix destruction and modulation of host responses. Periodontol. 2000 24, 153-192 (2000).
41. Potempa J, Sroka A, Imamura I et al.: Gingipains, the major cysteine proteinases and virulence factors of Porphyromonas gingivalis: structure, function and assembly of multidomain protein complexes. Curr. Protein Pept. Sci. 4, 397-407 (2003).
42. Schenkein HA, Flecther HM, Bodnar M et al.: Increased opsonisation of a prtH-defective mutant of Porphyromonas gingivalis W83 is caused by reduced degradation of complement-derived opsonins. J. Immunol. 54, 5331-5337 (1995).
43. Kesavalu L, Holt SC, Ebersole JL: Trypsin-like protease activity of Porphyromonas gingivalis as a potential virulence factor in the murine lesion model. Microb. Pathogenesis. 20, 1-10 (1996).
44. Tokuda M, Duncan MJ, Cho MI et al.: Role of Porphyromonas gingivalis protease activity in colonization of oral surfaces. Infect. Immun. 64, 4067-4078 (1996).
45. Curtis MA, Aduse-Opoku J, Rangarajan M: Cysteine proteases of Porphyromonas gingivalis. Crit. Rev. Oral Biol. Med. 12(3), 192-216 (2001).
46. Chen JM, Rawlings ND, Stevens RAE et al.: Identification of the active site of legumain links it to caspases, clostripain and gingipains in a new clan of cysteine endopeptidases. FEBS Lett. 441 (3), 361-365 (1998).
47. Curtis MA, Kuramitsu HK, Lantz M et al.: Molecular genetics and nomenclature of proteases of Porphyromonas gingivalis. J. Periodontal Res. 34(8), 464-472 (1999).
48. Nakayama K, Kadowaki T, Okamoto K et al.: Construction and characterization of arginine-specific cysteine proteinase (Arg-gingipain)-deficient mutants of Porphyromonas gingivalis. Evidence for significant contribution of Arg-gingipain to virulence. J. Biol. Chem. 270(40), 23619-23626 (1995).
49. Fletcher HM, Schenkein HA, Morgan RM et al.: Virulence of a Porphyromonas gingivalis W83 mutant defective in the prtH gene. Infect. Immun. 63(4), 1521-1528 (1995).
50. Okamoto K, Nakayama K, Kadowaki T et al.: Involvement of a lysine-specific cysteine proteinase in hemoglobin adsorption and heme accumulation by Porphyromonas gingivalis. J. Biol. Chem. 273(33), 21225-21231 (1998).
51. Tokuda M, Karunakaran T, Duncan M et al.: Role of Arg-gingipain a in virulence of Porphyromonas gingivalis. Infect. Immun. 66(3), 1159-1166 (1998).
52. Barkocy-Gallagher GA, Foley JW, Lantz MS: Activities of the Porphyromonas gingivalis prtP proteinase determined by construction of prtP-deficient mutants and expression of the gene in bacteroides species. J. Bacteriol. 181(1), 246-255 (1999).
53. Shi Y, Ratnayake DB, Okamoto K et al.: Genetic analyses of proteolysis, hemoglobin binding, and hemagglutination of Porphyromonas gingivalis. Construction of mutants with a combination of rgpA, rgpB, kgp, and hagA. J. Biol. Chem. 274(25), 17955-17960 (1999).
54. O'Brien-Simpson NM, Paolini RA, Hoffmann B et al.: Role of RgpA, RgpB, and Kgp proteinases in virulence of Porphyromonas gingivalis W50 in a murine lesion model. Infect. Immun. 69(12), 7527-7534 (2001).
55. Veith PD, Talbo GH, Slakeski N et al.: Major outer membrane proteins and proteolytic processing of RgpA and Kgp of Porphyromonas gingivalis W50. Biochem. J. 363(1), 105-115 (2002).
56. Chen ZX, Potempa J, Polanowski A et al.: Purification and characterization of a 50-kDa cysteine proteinase (gingipain) from Porphyromonas gingivalis. J. Biol. Chem. 267(26), 18896-18901 (1992).
57. Pike R, McGraw WT, Potempa J et al.: Lysine- and arginine-specific proteinases from Porphyromonas gingivalis: isolation, characterization and evidence for existence of complexes with hemagglutinins. J. Biol. Chem. 269, 406-411 (1994).
58. Cutler CW, Kalmar JR, Genco CA: Pathogenic strategies of the oral anaerobe, Porphyromonas gingivalis. Trends Microbiol. 3(2), 45-51 (1995).
59. Imamura T, Travis J, Potempa J: The biphasic virulence activities of gingipains: activation and inactivation of host proteins. Curr. Protein Pept. Sci. 4, 443-450 (2003).
60. Brecx MC, Schlegel K, Gehr P et al.: Comparison between histological and clinical parameters during human experimental gingivitis. J. Periodontal Res. 22(1), 50-57 (1987).
61. Imamura T, Potempa J, Pike RN et al.: Dependence of vascular permeability enhancement on cysteine proteinases in vesicles of Porphyromonas gingivalis. Infect. Immun. 63, 1999-2003 (1995).
62. Imamura T, Pike RN, Potempa J et al.: Pathogenesis of periodontitis: a major arginine-specific cysteine proteinase from Porphyromonas gingivalis induces vascular permeability enhancement through activation of the kallikrein/kinin pathway. J. Clin. Invest. 94(1), 361-367 (1994).
63. Imamura T, Potempa J, Pike RN et al.: Effect of free and vesicle-bound cysteine proteinases of Porphyromonas gingivalis on plasma clot formation: implications for bleeding tendency at periodontitis sites. Infect. Immun. 63(12), 4877-4882 (1995).
64. Imamura T, Potempa J, Tanase S et al.: Activation of blood coagulation factor X by arginine-specific cysteine proteinases (gingipain-Rs) from Porphyromonas gingivalis. J. Biol. Chem. 272(25), 16062-16067 (1997).
65. Imamura T, Banbula A, Pereira PJ et al.: Activation of human prothrombin by arginine-specific cysteine proteinases (gingipains R) from Porphyromonas gingivalis. J. Biol. Chem. 276(22), 18984-18991 (2001).
66. Imamura T, Tanase S, Hamamoto T et al.: Activation of blood coagulation factor IX by gingipains R, arginine-specific cysteine proteinases from Porphyromonas gingivalis. Biochem. J. 353(2), 325-331 (2001).
67. Bar-Shavit R, Kahn A, Wilner GD et al.: Monocyte chemotaxis: stimulation by specific exosite region in thrombin. Science 220(4598), 728-731 (1983).
68. DeMichele MA, Moon DG, Fenton JW 2nd et al.: Thrombin's enzymatic activity increases permeability of endothelial cell monolayers. J. Appl. Physiol. 69(5), 1599-1606 (1990).
69. Imamura T: The role of gingipains in the pathogenesis of periodontal disease. J. Periodontol. 74(1), 111-118 (2003).
70. Patridge NC, Hillyard CJ, Nolan RD et al.: Regulation of prostaglandin production by osteoblast-rich calvarial cells. Prostaglandins 30, 527-539 (1985).
71. Nawroth PP, Stern DM: Implication of thrombin formation on the endothelial cell surface. Semin. Thromb. Hemost. 12, 197-199 (1986).
72. Jones A, Geczy CL: Thrombin and factor Xa enhance the production of interleukin-1. Immunology 71, 236-241 (1990).
73. Hosotaki K, Imamura T, Potempa J et al.: Activation of protein C by arginine-specific cysteine proteinases (gingipains-R) from Porphyromonas gingivalis. Biol. Chem. 380(1), 75-80 (1999).
74. Lantz MS, Allen RD, Duck LW et al.: Identification of Porphyromonas gingivalis components that mediate its interactions with fibronectin. J. Bacteriol. 173(14), 4263-4270 (1991).
75. Pike RN, Potempa J, McGraw W et al.: Characterization of the binding activities of proteinase-adhesin complexes from Porphyromonas gingivalis. J. Bacteriol. 178(10), 2876-2882 (1996).
76. Imamura T, Potempa J, Travis J: Comparison of pathogenic properties between two types of arginine-specific cysteine proteinases. (gingipains-R) from Porphyromonas gingivalis. Microb. Pathog. 29, 155-183 (2000).
77. Ryan ME, Golub LM: Modulation of matrix metalloproteinase activities in periodontitis as a treatment strategy. Periodontol. 2000 24(1), 226-238 (2000).
78. Sorsa T, Ingman T, Suomalainen K et al.: Identification of proteases from periodontopathic bacteria as activators of latent neutrophil and fibroblast-type interstitial collagenase. Infect. Immun. 60, 4491-4495 (1992).
79. Decarlo AA, Windsor LJ Jr, Bodden MK et al.: Activation and novel processing of matrix metalloproteinases by a thiol-proteinase from the oral anaerobe Porphyromonas gingivalis. J. Dent. Res. 76(6), 1260-1270 (1997).
80. Okamoto T, Akaike T, Suga M et al.: Activation of human matrix metalloproteinases by various bacterial proteinases. J. Biol. Chem. 272(9), 6059-6066 (1997).
81. Kuramitsu HK: Proteases of Porphyromonas gingivalis: what don't they do? Oral Microbiol. Immunol. 13(5), 263-270 (1998).
82. Grayson R, Douglas CWI, Heath J et al.: Activation of human matrix metalloproteinase 2 by gingival crevicular fluid and Porphyromonas gingivalis. J. Clin. Periodontol. 30(6), 542-550 (2003).
83. Grant GA, Goldberg GI, Wilhelm SM et al.: Activation of extracellular matrix metalloproteases by proteases and organomercurials. Maxtrix 1(Suppl. 1), 217-223 (1992).
84. Scragg MA, Cannon SJ, Rangarajan M et al.: Targeted disruption of fibronectin-integrin interactions in human gingival fibroblasts by the RI protease of Porphyromonas gingivalis W50. Infect. Immun. 67(4), 1837-1843 (1999).
85. Smalley JW, Silver J, Marsh PJ et al.: The periodontopathogen Porphyromonas gingivalis binds iron protoporphyrin IX in the mu-oxo dimeric form: an oxidative buffer and possible pathogenic mechanism. Biochem. J. 331, 681-685 (1998).
86. 12) biosynthesis in Porphyromonas gingivalis. Identification and characterization of a functional corrin pathway. J. Biol. Chem. 275(51), 40316-40323 (2000).
87. Kusaba A, Ansai T, Akifusa S et al.: Cloning and expression of a Porphyromonas gingivalis gene for protoporphyrinogen oxidase by complementation of a hemG mutant of Escherichia coli. Oral Microbiol. Immunol. 17, 290-295 (2002).
88. Barua PK, Dyer DW, Neiders ME: Effect of iron limitation on Bacteroides gingivalis. Oral Microbiol. Immunol. 5(5), 263-268 (1990).
89. Shizukuishi S, Tazaki K, Inoshita E et al.: Effect of concentration of compounds containing iron on the growth of Porphyromonas gingivalis. FEMS Microbiol. Lett. 131(3), 313-317 (1995).
90. Lewis JP, Dawson JA, Hannis JC et al.: Hemoglobinase activity of the lysine gingipain protease (Kgp) of Porphyromonas gingivalis W83. J. Bacteriol. 181(16), 4905-4913 (1999).
91. Dashper SG, Cross KJ, Slakeski N et al.: Hemoglobin hydrolysis and heme acquisition by Porphyromonas gingivalis. Oral Microbiol. Immunol. 19(1), 50-56 (2004).
92. Ossovskaya VS, Bunnett NW: Protease-activated receptors: contribution to physiology and disease. Physiol. Rev. 84(2), 579-621 (2004).
93. Steinhoff M, Buddenkotte J, Shpacovitch V et al.: Proteinase-activated receptors: transducers of proteinase-mediated signaling in inflammation and immune response. Endocr. Rev. 26(1), 1-43 (2005).
94. Macfarlane SR, Seatter MJ, Kanke T et al.: Proteinase-activated receptors. Pharmacol. Rev. 53(2), 245-282 (2001).
95. Lourbakos A, Chinni C, Thompson P et al.: Cleavage and activation of proteinase-activated receptor-2 on human neutrophils by gingipain-R from Porphyromonas gingivalis. FEBS Lett. 435(1), 45-48 (1998).
96. Lourbakos A, Potempa J, Travis J et al.: Arginine-specific protease from Porphyromonas gingivalis activates protease-activated receptors on human oral epithelial cells and induces interleukin-6 secretion. Infect. Immun. 69(8), 5121-5130 (2001).
97. Lourbakos A, Yuan YP, Jenkins AL et al.: Activation of protease-activated receptors by gingipains from Porphyromonas gingivalis leads to platelet aggregation: a new trait in microbial pathogenicity. Blood 97(12), 3790-3797 (2001).
98. Uehara A, Muramoto K, Imamura T et al.: Arginine-specific gingipains from Porphyromonas gingivalis stimulate production of hepatocyte growth factor (scatter factor) through protease-activated receptors in human gingival fibroblasts in culture. J. Immunol. 175(9), 6076-6084 (2005).
99. Tancharoen S, Sarker KP, Imamura T et al.: Neuropeptide release from dental pulp cells by RgpB via proteinase-activated receptor-2 signaling. J. Immunol. 174(9), 5796-5804 (2005).
100. Uehara A, Imamura T, Potempa J et al.: Gingipains from Porphyromonas gingivalis synergistically induce the production of proinflammatory cytokines through protease-activated receptors with Toll-like receptor and NOD1/2 ligands in human monocytic cells. Cell. Microbiol. 10(5), 1181-1189 (2008).
101. Holzhausen M, Spolidorio LC, Ellen RP et al.: Protease-activated receptor-2 activation: a major role in the pathogenesis of Porphyromonas gingivalis infection. Am. J. Pathol. 168(4), 1189-1199 (2006).
102. Sugawara S, Nemoto E, Tada H et al.: Proteolysis of human monocyte CD14 by cysteine proteinases (gingipains) from Porphyromonas gingivalis leading to lipopolysaccharide hyporesponsiveness. J. Immunol. 165(1), 411-418 (2000).
103. Tada H, Sugawara S, Nemoto E et al.: Proteolysis of CD14 on human gingival fibroblasts by arginine-specific cysteine proteinases from Porphyromonas gingivalis leading to down-regulation of lipopolysaccharide-induced interleukin-8 production. Infect. Immun. 70, 3304-3307 (2002).
104. Yun PLW, Decarlo AA, Hunter N: Gingipains of Porphyromonas gingivalis modulate leukocyte adhesion molecule expression induced in human endothelial cells by ligation of CD99. Infect. Immun. 74(3), 1661-1672 (2006).
105. Kitamura Y, Hirofuji T, Yoneda M et al.: Cleavage of surface proteins on human T cells by the culture supernatant of Porphyromonas gingivalis. Dent. J. 36, 109-112 (2000).
106. Kitamura Y, Matono S, Aida Y et al.: Gingipains in the culture supernatant of Porphyromonas gingivalis cleave CD4 and CD8 on human T cells. J. Periodontal Res. 37(6), 464-468 (2002).
107. + T cells preferentially down-regulates surface CD2 and CD4 with little affect on co-stimulatory molecule expression. Microb. Pathog. 38(2-3), 85-96 (2005).
108. Fishburn CS, Slaney JM, Carman RJ et al.: Degradation of plasma proteins by the trypsin-like enzyme of Porphyromonas gingivalis and inhibition of protease activity by a serine protease inhibitor of human plasma. Oral Microbiol. Immunol. 6(4), 209-215 (1991).
109. Gregory RL, Kim DE, Kindle JC et al.: Immunoglobulin-degrading enzymes in localized juvenile periodontitis. J. Periodon. Res. 27(3), 176-183 (1992).
110. Popadiak K, Potempa J, Riesbeck K et al.: Biphasic effect of gingipains from Porphyromonas gingivalis on the human complement system. J. Immunol. 178(11), 7242-7250 (2007).
111. Potempa M, Potempa J, Okroj M et al.: Binding of complement inhibitor C4b-binding protein contributes to serum resistance of Porphyromonas gingivalis. J. Immunol. 181(8), 5537-5544 (2008).
112. Wilson M, Seymour R, Henderson B: Bacterial perturbation of cytokine networks. Infect. Immun. 66(6), 2401-2409 (1998).
113. Sakai A, Ohshima M, Sugano N et al.: Profiling the cytokines in gingival crevicular fluid using a cytokine antibody array. J. Periodontol. 77, 856-864 (2006).
114. Zhong Y, Slade GD, Beck JD et al.: Gingival crevicular fluid interleukin-1β, prostaglandin E2 and periodontal status in a community population. J. Clin. Periodontol. 34, 285-293 (2007).
115. Fletcher J, Reddi K, Poole S et al.: Interactions between periodontopathogenic bacteria and cytokines. J. Periodontal Res. 32(1), 200-205 (1997).
116. Calkins CC, Platt K, Potempa J et al.: Inactivation of tumor necrosis factor-α by proteinases (gingipains) from the periodontal pathogen, Porphyromonas gingivalis. Implications of immune evasion. J. Biol. Chem. 273(12), 6611-6614 (1998).
117. Mikolajczyk-Pawlinska J, Travis J, Potempa J: Modulation of interleukin-8 activity by gingipains from Porphyromonas gingivalis: implications for pathogenicity of periodontal disease. FEBS Lett. 440(3), 282-286 (1998).
118. Banbula A, Bugno M, Kuster A et al.: Rapid and efficient inactivation of IL-6 gingipains, lysine- and arginine-specific proteinases from Porphyromonas gingivalis. Biochem. Biophys. Res. Commun. 261(3), 598-602 (1999).
119. Yun PLW, DeCarlo AA, Hunter N: Modulation of major histocompatibility complex protein expression by human γ-interferon mediated by cysteine proteinase-adhesin polyproteins of Porphyromonas gingivalis. Infect. Immun. 67(6), 2986-2995 (1999).
120. Oleksy A, Banbula A, Bugno M et al.: Proteolysis of interleukin-6 receptor (IL-6R) by Porphyromonas gingivalis cysteine proteinases (gingipains) inhibits interleukin-6-mediated cell activation. Microb. Pathogen. 32, 173-181 (2002).
121. Mezyk-Kopec R, Bzowska M, Potempa J et al.: Inactivation of membrane tumor necrosis factor α by gingipains from Porphyromonas gingivalis. Infect. Immun. 73(3), 1506-1514 (2005).
122. Yun PLW, Decarlo AA, Collyer C et al.: Hydrolysis of interleukin-12 by Porphyromonas gingivalis major cysteine proteinases may affect local γ interferon accumulation and the Th1 or Th2 T-cell phenotype in periodontitis. Infect. Immun. 69(9), 5650-5660 (2001).
123. Gamonal J, Bascones A, Acevedo A et al.: Apoptosis in chronic adult periodontitis analyzed by in situ DNA breaks, electron microscopy, and immunohistochemistry. J. Periodont. 72(4), 517-525 (2001).
124. Sheets SM, Robles-Price AG, McKenzie RM et al.: Gingipain-dependent interactions with the host are important for survival of Porphyromonas gingivalis. Front. Biosci. 13, 3215-3238 (2008).
125. Chen Z, Casiano CA, Fletcher HM: Protease-active extracellular protein preparations from Porphyromonas gingivalis W83 induce N-cadherin proteolysis, loss of cell adhesion, and apoptosis in human epithelial cells. J. Periodont. 72(5), 641-650 (2001).
126. Sheets SM, Potempa J, Travis J et al.: Gingipains from Porphyromonas gingivalis W83 induce cell adhesion molecule cleavage and apoptosis in endothelial cells. Infect. Immun. 73(3), 1543-1552 (2005).
127. Sheets SM, Potempa J, Travis J et al.: Gingipains from Porphyromonas gingivalis W83 synergistically disrupt endothelial cell adhesion and can induce caspase-independent apoptosis. Infect. Immun. 74(10), 5667-5678 (2006).
128. Gwak GY, Yoon JH, Yu SJ et al.: Anti-apoptotic N-cadherin signaling and its prognostic implication in human hepatocellular carcinomas. Oncol. Reports 15(5), 1117-1123 (2006).
129. Pavloff N, Potempa J, Pike RN et al.: Molecular cloning and structural characterisation of the Arg-gingipain proteinase of Porphyromonas gingivalis. Biosynthesis as a proteinase-adhesin polyprotein. J. Biol. Chem. 270, 1007-1010 (1995).
130. Nakayama K: Domain-specific rearrangement between the two Arg-gingipain-encoding genes in Porphyromonas gingivalis: possible involvement of nonreciprocal recombination. Microbiol. Immunol. 41(3), 185-195 (1997).
131. Rangarajan M, Aduse-Opoku J, Slaney JM et al.: The prpR1 and prR2 arginine-specific protease genes of Porphyromonas gingivalis W50 produce five biochemically distinct enzymes. Mol. Microbiol. 23(5), 955-965 (1997).
132. Mikolajczyk-Pawlinska J, Kordula T, Pavloff N et al.: Genetic variation of Porphyromonas gingivalis genes encoding gingipains, cysteine proteinases with arginine or lysine specificity. Biol. Chem. 379(2), 205-211 (1998).
133. Barkocy-Gallagher GA, Han N, Patti JM et al.: Analysis of the prtP gene encoding porphypain, a cysteine proteinase of Porphyromonas gingivalis. J. Bacteriol. 17 8(10), 2734-2741 (1996).
134. Okamoto K, Kadowaki T, Nakayama K et al.: Cloning and sequencing of the gene encoding a novel lysine-specific cysteine proteinase (Lys-gingipain) in Porphyromonas gingivalis: structural relationship with the arginine-specific cysteine proteinase (Arg-gingipain). J. Biochem. (Tokyo) 120, 398-406 (1996).
135. Pavloff N, Pemberton PA, Potempa J et al.: Molecular cloning and characterization of Porphyromonas gingivalis lysine-specific gingipain. A new member of an emerging family of pathogenic bacterial cysteine proteinases. J. Biol. Chem. 112(5), 1595-1600 (1997).
136. Lewis JP, Macrina FL: IS195, an insertion sequence-like element associated with protease genes in Porphyromonas gingivalis. Infect. Immun. 66(7), 3035-3042 (1998).
137. Slakeski N, Cleal SM, Bhogal PS et al.: Characterization of a Porphyromonas gingivalis gene prtK that encodes a lysine-specific cysteine proteinase and three sequence-related adhesins. Oral Microbiol. Immunol. 14(2), 92-97 (1999).
138. Han N, Lepine G, Whitlock J et al.: The Porphyromonas gingivalis prtP/kgp homologue exists as two open reading frames in strain 381. Oral Dis. 4, 170-179 (1998).
139. Slakeski N, Bhogal PS, O'Brien-Simpson NM et al.: Characterization of a second cell-associated Arg-specific cysteine proteinase of Porphyromonas gingivalis and identification of an adhesin-binding motif involved in association of the prtR and prtK proteinases and adhesins into large complexes. Microbiology 144(Pt 6), 1583-1592 (1998).
140. Bhogal PS, Slakeski N, Reynolds EC: A cell-associated protein complex of Porphyromonas gingivalis W50 composed of Arg- and Lys-specific cysteine proteinases and adhesins. Microbiology 143, 2485-2495 (1997).
141. Okamoto K, Misumi Y, Kadowaki T et al.: Structural characterization of argingipain, a novel arginine-specific cysteine proteinase as a major periodontal pathogenic factor from Porphyromonas gingivalis. Arch. Biochem. Biophys. 316(2), 917-925 (1995).
142. Rangarajan M, Smith SJ, U S et al.: Biohemical characterization of the arginine-specific proteases of Porphyromonas gingivalis W50 suggests a common precursor. Biochem. J. 323(Pt 3), 701-709 (1997).
143. Curtis MA, Aduse-Opoku J, Slaney JM et al.: Characterization of an adherence and antigenic determinant of the Argl protease of Porphyromonas gingivalis which is present on multiple gene products. Infect. Immun. 64(7), 2532-2539 (1996).
144. Curtis MA, Thickett A, Slaney JM et al.: Variable carbohydrate modifications to the catalytic chains of the RgpA and RgpB proteases of Porphyromonas gingivalis W50. Infect. Immun. 67(8), 3816-3823 (1999).
145. Seers CA, Slakeski N, Veith PD et al.: The RgpB C-terminal domain has a role in attachment of RgpB to the outer membrane and belongs to a novel C-terminal-domain family found in Porphyromonas gingivalis. J. Bacteriol. 188(17), 6376-6386 (2006).
146. Nguyen K-A, Travis J, Potempa J: Does the importance of the C-terminal residues in the maturation of RgpB from Porphyromonas gingivalis reveal a novel mechanism for protein export in a subgroup of Gram-negative bacteria? J. Bacteriol. 189(3), 833-843 (2007).
147. Gallagher A, Aduse-Opoku J, Rangarajan M et al.: Glycosylation of the Arg- gingipains of Porphyromonas gingivalis and comparison with glycoconjugate structure and synthesis in other bacteria. Curr. Protein Pept. Sci. 4(6), 427-441 (2003).
148. Vanterpool E, Roy F, Fletcher HM: The vimE gene downstream of vimA is independently expressed and is involved in modulating proteolytic activity in Porphyromonas gingivalis W83. Infect. Immun. 72(10), 5555-5564 (2004).
149. Vanterpool E, Roy F, Fletcher HM: Inactivation of vimF, a putative glycosyltransferase gene downstream of vimE, alters glycosylation and activation of the gingipains in Porphyromonas gingivalis W83. Infect. Immun. 73(7), 3971-3982 (2005).
150. Vanterpool E, Roy F, Sandberg L et al.: Altered gingipain maturation in vimA- and vimE-defective isogenic mutants of Porphyromonas gingivalis. Infect. Immun. 73(3), 1357-1366 (2005)
151. Vanterpool E, Roy F, Zhan W et al.: VimA is part of the maturation pathway for the major gingipains of Porphyromonas gingivalis W83. Microbiology 152(Pt 11), 3383-3389 (2006).
152. Fujimura S, Nakamura T: Isolation and characterization of a protease from Bacteroides gingivalis. Infect. Immun. 55(3), 716-720 (1987).
153. Bedi GS: Comparative study of four proteases from spent culture media of Porphyromonas gingivalis (FAY-19M-1). Prep. Biochem. Biotechnol. 25(3), 133-154 (1995).
154. Takii R, Kadowaki T, Baba A et al.: A functional virulence complex composed of gingipains, adhesins, and lipopolysaccharide shows high affinity to host cells and matrix proteins and escapes recognition by host immune systems. Infect. Immun. 73(2), 883-893 (2005).
155. Potempa J, Pike R, Travis J: The multiple forms of trypsin-like activity present in various strains of Porphyromonas gingivalis are due to the presence of either Arg-gingipain or Lys-gingipain. Infect. Immun. 63(4), 1176-1182 (1995).
156. Eichinger A, Beisel HG, Jacob U et al.: Crystal structure of gingipain R: an Arg-specific bacterial cysteine proteinase with a caspase-like fold. EMBO J. 18(20), 5453-5462 (1999).
157. Sato K, Sakai E, Veith PD et al.: Identification of a new membrane-associated protein that influences transport/maturation of gingipains and adhesins of Porphyromonas gingivalis. J. Biol. Chem. 280(10), 8668-8677 (2005).
158. Cianciotto NP: Type II secretion: a protein secretion system for all seasons. Trends Microbiol. 13(12), 581-588 (2005).
159. Pugsley AP, Francetic O, Driessen AJ et al.: Getting out: protein traffic in prokaryotes. Mol. Microbiol. 52(1), 3-11 (2004).
160. Aduse-Opoku J, Muir J, Slaney JM et al.: Characterization, genetic analysis, and expression of a protease antigen (PrpRI) of Porphyromonas gingivalis W50. Infect. Immun. 63(12), 4744-4754 (1995).
161. Han N, Whitlock J, Progulske-Fox A: The hemagglutinin gene A (hagA) of Porphyromonas gingivalis 381 contains four large, contiguous, direct repeats. Infect. Immun. 64(10), 4000-4007 (1996).
162. Aduse-Opoku J, Slaney JM, Rangarajan M et al.: The Tla protein of Porphyromonas gingivalis W50: a homolog of the RI protease precursor (PrpRI) is an outer membrane receptor required for growth on low levels of hemin. J. Bacteriol. 179(15), 4778-4788 (1997).
163. Kelly CG, Booth V, Kendal H et al.: The relationship between colonization and haemagglutination inhibiting and B cell epitopes of Porphyromonas gingivalis. Clin. Exp. Immunol. 110, 285-291 (1997).
164. Nakayama K, Ratnayake DB, Tsukuba T et al.: Haemoglobin receptor protein is intragenically encoded by the cysteine proteinase-encoding genes and the haemagglutinin-encoding gene of Porphyromonas gingivalis. Mol. Microbiol. 27(1), 51-61 (1998).
165. Chen T, Nakayama K, Belliveau L et al.: Porphyromonas gingivalis gingipains and adhesion to epithelial cells. Infect. Immun. 69(5), 3048-3056 (2001).
166. Kamaguchi A, Ohyama T, Sakai E et al.: Adhesins encoded by the gingipain genes of Porphyromonas gingivalis are responsible for co-aggregation with Prevotella intermedia. Microbiology 149(5), 1257-1264 (2003).
167. Chen T, Duncan MJ: Gingipain adhesin domains mediate Porphyromonas gingivalis adherence to epithelial cells. Microb. Pathogen. 36(4), 205-209 (2004).
168. O'Brien-Simpson NM, Pathirana RD, Paolini RA et al.: An immune response directed to proteinase and adhesin functional epitopes protects against Porphyromonas gingivalis-induced periodontal bone loss. J. Immunol. 175(6), 3980-3989 (2005).
169. Pathirana RD, O'Brien-Simpson NM, Visvanathan K et al.: Flow cytometric analysis of adherence of Porphyromonas gingivalis to oral epithelial cells. Infect. Immun. 75(5), 2484-2492 (2007).
170. Booth V, Ashley FP, Lehner T: Passive immunization with monoclonal antibodies against Porphyromonas gingivalis in patients with periodontitis. Infect. Immun. 64(2), 422-427 (1996).
171. Shibata Y, Hayakawa M, Takiguchi H et al.: Determination-and characterization of the hemagglutinin-associated short motifs found in Porphyromonas gingivalis multiple gene products. J. Biol. Chem. 274(8), 5012-5020 (1999).
172. O'Brien-Simpson NM, Paolini RA, Reynolds EC: RgpA-Kgp peptide-based immunogens provide protection against Porphyromonas gingivalis challenge in a murine lesion model. Infect. Immun. 68(7), 4055-4063 (2000).
173. Signäs C, Raucci G, Jönsson K et al.: Nucleotide sequence of the gene for a fibronectin-binding protein from Staphylococcus aureus: use of this peptide sequence in the synthesis of biologically active peptides. Proc. Natl Acad. Sci. USA 86(2), 699-703 (1989).
174. Westerlund T, Korhonen K: Bacterial proteins binding to the mammalian extracellular matrix. Mol. Microbiol. 9(4), 687-694 (1993).
175. Patti JM, Allen BL, McGavin MJ et al.: Mscramm-mediated adherence of microorganisms to host tissues. Annu. Rev. Microbiol. 48(1), 585-617 (1994).
176. Sakai E, Naito M, Sato K et al.: Construction of recombinant hemagglutinin derived from the gingipain-encoding gene of Porphyromonas gingivalis, identification of its target protein on erythrocytes, and inhibition of hemagglutination by an interdomain regional peptide. J. Bacteriol. 189(11), 3977-3986 (2007).